# FDA Inspection 1058864 - C.R. Bard Inc - June 08, 2018

Source: https://www.keypedia.com/records/fda_inspections/cr-bard-inc/1288f602-31c2-499f-a5fb-c263cba6a2d5
Source feed: FDA_Inspections

> FDA Inspection 1058864 for C.R. Bard Inc on June 08, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1058864
- Company Name: C.R. Bard Inc
- Inspection Date: 2018-06-08
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1237149 - 2024-11-12](https://www.keypedia.com/records/fda_inspections/cr-bard-inc/a1e7ec31-76c7-49ba-b215-91634376285a)
- [FDA Inspection 1237149 - 2024-11-12](https://www.keypedia.com/records/fda_inspections/cr-bard-inc/7f37f0bc-4dcc-411e-9110-1e0bb285da4c)
- [FDA Inspection 1237149 - 2024-11-12](https://www.keypedia.com/records/fda_inspections/cr-bard-inc/f619c81a-c78f-4151-9a0e-9902ff1cde9b)
- [FDA Inspection 1117926 - 2020-01-28](https://www.keypedia.com/records/fda_inspections/cr-bard-inc/44014c57-2eb2-4311-afd0-10578d917e61)
- [FDA Inspection 1058864 - 2018-06-08](https://www.keypedia.com/records/fda_inspections/cr-bard-inc/a5986255-f786-4387-bd29-fa2770b08a46)

Company: https://www.keypedia.com/companies/cr-bard-inc/b524a446-ee90-4fa3-b533-57237e560e3b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d